• International Comparison of Internet Information Source in Breast Cancer

    Nov 1, 2015, 00:00

  • Benefit-Risk of Vka for Atrial Fibrillation Before Doac- a Cohort Study in a Claims and Hospitalization Database

    Nov 1, 2015, 00:00

  • Patient Reported Outcome in Health Services Research- A Prospective Study of Orthopedic Surgery in Routine Care in Switzerland

    Nov 1, 2015, 00:00

  • Economic Analysis Of Evarrest® Sealant Matrix Compared With Standard Of Care In Severe Soft Tissue Surgical Bleeding- A German Hospital Perspective

    Nov 1, 2015, 00:00

  • Real World Data- Biologic Treatment for Naive Patient in the Lazio Region

    Nov 1, 2015, 00:00

  • Early Benefit Assessment And Uptake Of Pharmaceutical Innovations – Experiences From Germany 2011 To 2014

    Nov 1, 2015, 00:00

  • Orphan Drugs Assessment in Germany- A Comparison with Other International HTA Agencies

    Nov 1, 2015, 00:00

  • Systematic Literature Review of Adjunctive Anti-Epileptic Drug Trials In Patients With Primary Generalized Tonic-Clonic Seizures Illustrates Changes in Standard of Care Over 12-20 Years

    Nov 1, 2015, 00:00

  • Assessment of Direct Cost for Treatment of Influenza and Ari for Outpatient In Ukraine

    Nov 1, 2015, 00:00

  • Healthcare Costs In Psoriatic Arthritis Patients Newly Initiated on Apremilast or Biologic Therapies

    Nov 1, 2015, 00:00

  • Development Of A Patient-Reported Outcome (Pro) Assessment Of Core Non-Small Cell Lung Cancer (Nsclc) Symptoms

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Gefitinib as the First Line Treatment in Patients With Positive Egfr Mutation In Metastatic or Locally Advanced non-Small Cell

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Evaluation Comparing Biosimilar Bemfola to Gonal-F for the Treatment of Infertility in an Italian Contest

    Nov 1, 2015, 00:00

  • Individual and Societal Burden of Non-Adherence to Antidepressants in Brazil

    Nov 1, 2015, 00:00

  • Building a Bridge Between Clinical Evidence Research and Patient Preference Research

    Nov 1, 2015, 00:00

  • Opioid Addiction Treatment in the eu5- Market Access Levers for Emerging Brands Entering a Generic Market

    Nov 1, 2015, 00:00

  • Clinical And Economic Analysis Of Effectiveness Of Fondaparinux Sodium In The Treatment Of Acute Coronary Syndrome

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Evaluation Of The Use Of Trastuzumab For Subcutaneous Administration Compared To Intravenous Dosage Form In The Treatment Of Breast Cancer

    Nov 1, 2015, 00:00

  • The Cost-Of-Disease (Cod) In Central Retinal Vein Occlusion (Crvo) In Turkey- An Expert Panel Approach For Estimation of Costs

    Nov 1, 2015, 00:00

  • Drug Pricing Reform in China - An Analysis of Piloted Pricing Approaches in the Context of International Experience

    Nov 1, 2015, 00:00

  • What Is Ce Marking? How Technologies Are Classified, And How To Navigate The System

    Nov 1, 2015, 00:00

  • Leptospirosis; A Zoonotic, Morbid and Fatal Disease- A Record Viewing Study

    Nov 1, 2015, 00:00

  • Review Of The Current Status Of Ras Mutation Testing In Patients With Metastatic Colorectal Cancer (Mcrc)- Flash-Ras Study

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Scotland

    Nov 1, 2015, 00:00

  • Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking once Daily Teriflunomide Tablets in the United States

    Nov 1, 2015, 00:00

  • Estimation of The Relative Efficacy of Licensed Regimens for Genotype-1 Hcv Infection Using A Mixed Treatment Comparison

    Nov 1, 2015, 00:00

  • Cost-Utility of Fingolimod Compared With Dimethyl Fumarate (Dmf) In Highly Active Relapsing Remitting Multiple Sclerosis (Rrms) In England- Comparison of A Markov and Discrete Event Simulation Model

    Nov 1, 2015, 00:00

  • Cost Savings By The Use Of Bemiparin In The Treatment Of Patients With Venous Thromboembolism In Spain

    Nov 1, 2015, 00:00

  • Cognitive Debriefing And Usability Assessment Of The Eortc Qlq-C30 And Qlq-Br23 As Presented On Tablet And Handheld Devices

    Nov 1, 2015, 00:00

  • Cost of Illness (Out of Pocket Costs Paid By Patient) for T.B in Quetta City, Pakistan

    Nov 1, 2015, 00:00

  • Experts Consensus on The Future of Rare Diseases Care and Orphan Drugs Access In Spain- A Delphi Study

    Nov 1, 2015, 00:00

  • The Association between Disease Activity and Quality of Life among Patients with Ankylosing Spondylitis in Polish Population

    Nov 1, 2015, 00:00

  • Bayesian Econometric Modelling Of Observational Data For Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00

  • How Has The Smc Patient And Clinician Engagement (Pace) Process Been Used In Assessments Of End-Of-Life Medicines And Medicines To Treat Very Rare Conditions?

    Nov 1, 2015, 00:00

  • Management Of Sore Throat In Community Pharmacy In Fran A National Observational Study

    Nov 1, 2015, 00:00

  • Dispensing of Vitamin Products by Retail Pharmacies in South Africa

    Nov 1, 2015, 00:00

  • The Economic Consequences Of The Use Of Antibiotics In Belgium

    Nov 1, 2015, 00:00

  • Characteristics of Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents

    Nov 1, 2015, 00:00

  • The Cost-Of-Disease (Cod) In Diabetic Macular Edema (Dme) In Turkey- An Expert Panel Approach for Estimation of Costs

    Nov 1, 2015, 00:00

  • The Rise of Orphan Drugs In Europe Vs The United States- Comparing Orphan Drug Designations Between The Ema And Fda

    Nov 1, 2015, 00:00

  • Atrial Fibrillation And Anti-Coagulation Service Run By A Clinical Nurse Specialist

    Nov 1, 2015, 00:00

  • Evaluation Analysis of Smoking Population in Ulaanbaatar

    Nov 1, 2015, 00:00

  • Similarities and Differences In Orphan Drug Reimbursement In 16 European Countries

    Nov 1, 2015, 00:00

  • Current Process and Future Path for Health Economic Assessment of Pharmaceuticals in France

    Nov 1, 2015, 00:00

  • Improved Survival With Ipilimumab In Patients With Advanced Melanoma In Real-World Clinical Practi First Results Of The Dutch Melanoma Treatment Registry

    Nov 1, 2015, 00:00

  • Exenatide Once Weekly Plus Metformin for the Treatment of Type 2 Diabetes Mellitus- A Network Meta-Analysis of Randomised Controlled Trials

    Nov 1, 2015, 00:00

  • Indirect Treatment Comparison (Itc) To Demonstrate The Utility Of Oncolitbank- An Oncology Literature Registry

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of The Use of Daclatasvir for The Treatment of Hepatitis C Virus (Hcv) Genotypes 3, In The Italian Setting

    Nov 1, 2015, 00:00

  • Revision Sistemática De Estudios De Costo Efectividad De Intervenciones Sanitarias Para La Cesacion Del Hábito Tabáquico

    Nov 1, 2015, 00:00

  • Campañas de Medicamentos; Instrumento Publicitario Que Atenta Contra Los Genéricos y el Acceso a Medicamentos

    Nov 1, 2015, 00:00

  • Management of Statin Intolerance (Si) in Patients at High Risk for Cardiovascular (Cv) Events- Results of a Canadian Study

    Nov 1, 2015, 00:00

  • Cost Saving Associated With Glucose Meter Accuraccy In Spain

    Nov 1, 2015, 00:00

  • Trends in Non-Submissions in the UK

    Nov 1, 2015, 00:00

  • Development of Ms Budget Manager- A Practical Tool to Assist Alternative Stakeholders At Multiple Decision Levels In The Forecast And Financial Management For Multiple Sclerosis (Ms)

    Nov 1, 2015, 00:00

  • Patterns Of Medication Use In Chronic Kidney Disease Stage 5d- Emphasis On Medications For The Management Of Ckd-Mbd

    Nov 1, 2015, 00:00

  • Developing Bilingual Certificate Programs in Clinical Pharmacy

    Nov 1, 2015, 00:00

  • A Review of Patient Registries in Heart Failure Across European Union-5 Countries

    Nov 1, 2015, 00:00

  • Skin Whitening Multiple Emulsions Loaded with Green Tea and Lotus Extracts- an Efficacy Study

    Nov 1, 2015, 00:00

  • An Update on Healthcare Resource Use and Economic Burden In Alzheimer’s Disease In The United States (Us) From A Medicare Sample Analysis

    Nov 1, 2015, 00:00

  • Outpatient Utilization and Quality Appraisal of Antibiotics in Turkey

    Nov 1, 2015, 00:00

  • Multi European Country Cost Consequence Comparison Of Floseal Matrix And Surgiflo Thrombin In Major And Severe Spine Surgeries

    Nov 1, 2015, 00:00

  • Economic Sanctions And Market Access for Pharmaceuticals- Case Studies With Russia, Cuba And Iran

    Nov 1, 2015, 00:00

  • Anti-Dementia Medicine Dispensing Patterns- A Community Pharmacy Database Analysis

    Nov 1, 2015, 00:00

  • Influence of Patient-Reported Outcomes (Pro) on Market Access Decisions In Markets With Centralized Healthcare Systems

    Nov 1, 2015, 00:00

  • Cost Analysis of Voriconazole Versus Liposomal Amphotericin B for Primary Therapy of Invasive Aspergillosis among High-Risk Hematologic Cancer Patients in Brazil

    Nov 1, 2015, 00:00

  • Challenges and Benefits of Conducting Value of Information Analysis from the Perspective of Industry- A Simulation Study

    Nov 1, 2015, 00:00

  • Therapy Of Depression In Cancer And Non-Cancer Patients In German Neuropsychiatric Practices

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Mirabegron Versus Antimuscarinic Treatments In Patients With Overactive Bladder From The Pespective Of The Spanish National Health Service

    Nov 1, 2015, 00:00

  • Closing The Financial Gap of Antiretroviral and Hiv Supplies For Sustainability of Hiv National Response In The Dominican Republic

    Nov 1, 2015, 00:00

  • Exploring Variation in Cost-Effectiveness Estimates in Studies that Evaluate Adult Pneumococcal Vaccination in Latin America

    Nov 1, 2015, 00:00

  • An Epidemiological Evaluation Of The Incidence Of Deep Venous Thrombosis And Pulmonary Embolism In Patients With Hip Or Knee Replacement Surgery And Of Its Impact On The Average Length Of Stay And Hospitalization Cost

    Nov 1, 2015, 00:00

  • Risk Of Pneumonia Associated With The Use Of Ics/Laba- A Retrospective Cohort Study In Korea

    Nov 1, 2015, 00:00

  • Resource Use And Exacerbations Of Chronic Obstructive Pulmonary Disease (Copd) By Gold Categories

    Nov 1, 2015, 00:00

  • Characteristics and Outcomes of Patients with Dengue Viral Infection During The Hospitalization At Tertiary Care Hospital

    Nov 1, 2015, 00:00

  • A Pragmatic Approach to Data Source Selection for use In Real-World Evidence (Rwe) Generation

    Nov 1, 2015, 00:00

  • A Literature Review To Evaluate The Pharmacoeconomic Value Of Ranolazine For The Treatment Of Symptomatic Chronic Stable Angina

    Nov 1, 2015, 00:00

  • Health And Economic Outcomes Related to Delay Between Medical Indication and Treatment With Ranibizumab In Age-Related Macular Degeneration In Greece

    Nov 1, 2015, 00:00

  • Diabetes Duration and Severity and Labour Market Outcomes In Mexico

    Nov 1, 2015, 00:00

  • Health-Related Quality of Life In Patients With Adrenal Insufficiency Receiving Plenadren Compared With Immediate-Release Hydrocortisone

    Nov 1, 2015, 00:00

  • Cost of Drug-Related Monitoring Requirements for Glatiramer Acetate and Other Multiple Sclerosis Disease-Modifying Therapies (Dmts)

    Nov 1, 2015, 00:00

  • Economic Considerations In Clinical Guidelines - Are Patient Perspectives Considered?

    Nov 1, 2015, 00:00

  • Development of A Screening Tool to Support Identification of Patients With Secondary Progressive Multiple Sclerosis (Spms)

    Nov 1, 2015, 00:00

  • Patient Benefits And Cost Savings Predicted For Mineralocorticoid-Receptor Antagonist Treatment Of Early And Advanced Diabetic Kidney Disease

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Intravitreal Aflibercept Compared with Ranibizumab-Prn in Patients with wet Age-Related Macular Degeneration (Wamd)

    Nov 1, 2015, 00:00

  • The Cost–Effectiveness Of Regorafenib In The Treatment Of Patients With Metastatic Colorectal Cancer (Mcrc) Who Have Progressed After Standard Therapies In Turkey

    Nov 1, 2015, 00:00

  • Off-Label Use of Intravenous Immunoglogulins (IVIGS)- Funding Mechanisms in France, Germany, Italy, Spain and the United Kingdom (EU5)

    Nov 1, 2015, 00:00

  • Treatment Satisfaction With Disease Modifying Therapies In Multiple Sclerosis- A Systematic Review of Studies Using The Treatment Satisfaction Questionnaire For Medication (Tsqm)

    Nov 1, 2015, 00:00

  • Review Of Comorbidity Measures To Predict Economic Outcomes In Real-Life Database Studies

    Nov 1, 2015, 00:00

  • Does The Atu Process Have An Impact On Time To Market Launch?

    Nov 1, 2015, 00:00

  • Comparative Effectiveness of Ticagrelor Vs. Prasugrel in Patients with Acute Coronary Syndrome

    Nov 1, 2015, 00:00

  • Envolvimento do Público no Processo de Incorporação de Tecnologias no Sus

    Nov 1, 2015, 00:00

  • Weight Loss Treatment Patterns in Mexico

    Nov 1, 2015, 00:00

  • Incorporation Of Evidence Based Medicine Into The European Observatory On Health Systems And Policies Document Describing The Health Systems Of Countries Not Belonging To The European Union

    Nov 1, 2015, 00:00

  • Cart Analysis As A Tool To Determine Optimal Treatment Intensification Time In Diabetes

    Nov 1, 2015, 00:00

  • Selecting Evidence-Based Preventive Treatment Thresholds By Optimizing Preferred Outcomes

    Nov 1, 2015, 00:00

  • The Diabetes Telephone Study- Design and Challenges of a Pragmatic Cluster Randomized Trial to Improve Diabetic Peripheral Neuropathy Treatment

    Nov 1, 2015, 00:00

  • Economic Burden of Pneumococcal Infections In Children Under Five Years Old

    Nov 1, 2015, 00:00

  • Health Economic Programming Using Royston-Parmar “Hazard Rate” Models- Providing Flexibility and Speed for Event Modelling In Cohort and Des Models

    Nov 1, 2015, 00:00

  • The Economics of the Treatment and Follow-Up of Patients with Glioblastoma

    Nov 1, 2015, 00:00

  • Utility Values for Health Technology Assessment- Learning Lessons from Economic Models of Pharmaceuticals Submitted to the French National Authority for Health (Has)

    Nov 1, 2015, 00:00

  • Prescription Patterns of Antidiabetic Treatment in the Elderly. Results from Southern Italy

    Nov 1, 2015, 00:00

  • Clinical and Economic Burden of Prostate Cancer

    Nov 1, 2015, 00:00

  • Additional Cost of Vte In Patients with Cancer- an Approach Based Databases

    Nov 1, 2015, 00:00

  • Romania’s New HTA System- What Progress have Innovative Drugs Made under the Points-Based System So Far?

    Nov 1, 2015, 00:00

  • Introducing Orange- An International Price Reference Tool

    Nov 1, 2015, 00:00

  • Investigation of the Living and its Impact to the Pregnants

    Nov 1, 2015, 00:00

  • Prediction Of Future Health Insurance Expenditures In Hungary According To Population Forecast Scenarios

    Nov 1, 2015, 00:00

  • Costo De Tuberculosis En Los Establecimientos De Salud Del Perú

    Nov 1, 2015, 00:00

  • A Study on Cytogenetic Analyses and Mecp2 Mutation With Dopamine And Serotonin In Rett Syndrome (Rtt)

    Nov 1, 2015, 00:00

  • Avaliação De Tecnologias No Tratamento Da Depressão Maior- Overview Sobre A Eficácia E Segurança Da Duloxetina, Venlafaxina E Trazodona Comparados À Fluoxetina

    Nov 1, 2015, 00:00

  • The Challenges in Evaluating the Cost-Effectiveness of Complex Interventions

    Nov 1, 2015, 00:00

  • Adherence of hiv patients switching to emtricitabina+tenofovir disoproxil+rilpivirin. Real world evidence from italian administrative databases

    Nov 1, 2015, 00:00

  • Treatment Strategies, Health Care Resource use and Costs of Aggressive Histological types of non-Hodgkin Lymphomas in the Slovak Republic. Results from the Cross-Sectional Survey in the Haematology-Oncological Centers

    Nov 1, 2015, 00:00

  • Economic Assessment of Eribulin Against Treatment of Physician’s Choice (Tpc) in Taiwan

    Nov 1, 2015, 00:00

  • Health Technology Assessment In Chronic Hepatitis C- Assessment of Decision Landscape And Manufacturer Inputs In Six Agencies

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Capsule Endoscopy Using For Diagnosing Small Bowel Crohn’s Disease

    Nov 1, 2015, 00:00

  • Analysis Of Primary And Secondary Apr-Drg Codes Of An Ischemic Stroke Admission

    Nov 1, 2015, 00:00

  • Improving Patient Quality of Life By Verifying And Enhancing Quality of Orthopaedic And Prosthetic Medical Devices

    Nov 1, 2015, 00:00

  • Evaluation of Psoriasis Patients’ Attitude to Risk- Benefit And Therapeutic Tradeoffs In Their Choice of Treatments

    Nov 1, 2015, 00:00

  • Choice of Antithrombotic Drug in non-Valvular Atrial Fibrillation Patients in Real-World Practice

    Nov 1, 2015, 00:00

  • Translatability Assessment and Linguistic Validation of The Patient-Reported Outcome Instrument for Irritable Bowel Syndrome With Diarrhea (Ibs-D Pro)

    Nov 1, 2015, 00:00

  • Overview of Generics Policies and Penetration in Japan

    Nov 1, 2015, 00:00

  • Trends In End-Of-Life Appraisals And Recommendations By Nice For Oncology Therapies

    Nov 1, 2015, 00:00

  • Fixed Combination Netupitant And Palonosetron Is A Cost-Effective Intervention For The Prevention Of Chemotherapy-Induced Nausea And Vomiting In The Uk

    Nov 1, 2015, 00:00

  • Clinical Multi-Criteria Decision Assessment (Cmda)- A Proposal for Applying Mcda to Compare Treatments in a Simultaneous, Transparent and Overall Way

    Nov 1, 2015, 00:00

  • Higher Accuracy Of Blood Glucose Monitoring Systems In Type 2 Insulin Treated Diabetic Patients In Spain- Clinical And Economic Impact

    Nov 1, 2015, 00:00

  • Qualitative Interviews To Provide In-Depth Understanding Of The Impact Of Non-Small Cell Lung Cancer (Nsclc) And Its Treatment On Of The Lives Of Patients And Their Families/Caregivers

    Nov 1, 2015, 00:00

  • Health Technological Supports to Detect Medication Errors- The Saniarp Case-Study

    Nov 1, 2015, 00:00

  • Economic Burden in Studies Published in 2014- What Type of Mental Health Disorders and Outcomes Have Been Most Commonly Assessed?

    Nov 1, 2015, 00:00

  • Indirect Comparison of Onabotulinum Vs. Oral Triptans for The Phrophylaxis Treatment of Chronic Migraine

    Nov 1, 2015, 00:00

  • Comparative Tolerability of New Antipsychotic Drugs in Schizophrenia- A Systematic Review and Meta-Analysis

    Nov 1, 2015, 00:00

  • Number of Osteoporosis Patients with Pathological Fractures By Gender in Outpatient Care in the Light of Physiotherapy Care in Hungary

    Nov 1, 2015, 00:00

  • Therapeutic Reference Pricing System In Slovenia From The Patients’ Perspective

    Nov 1, 2015, 00:00

  • Recommendations and Reimbursement Status of Orphan Drugs In Ue Countries

    Nov 1, 2015, 00:00

  • A Discrete Choice Experiment For Engaging Patients In Reimbursement Decision Making- Patient Preferences On Adjuvant Chemotherapy In Breast Cancer

    Nov 1, 2015, 00:00

  • Economic Evaluation of Chondroitin Sulfate and Non-Steroidal Antiinflammatory Drugs for The Treatment of Osteoarthritis

    Nov 1, 2015, 00:00

  • Ten Years of The International Pompe Survey- Patient Reported Outcomes As A Reliable Tool for Studying Treated and Untreated Children and Adults With Non-Classic Pompe Disease

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Fingolimod Versus Dimethyl Fumarate As A Second-Line Disease Modifying Treatment In Patients With Highly Active Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Simeprevir Plus Peginterferon/Ribavirin Cost-Effectiveness Analysis for the Treatment of Chronic Genotype 1 Hepatitis C in Mexico

    Nov 1, 2015, 00:00

  • Budget Impact Analysis Of Phased Radiofrequency (Rf) Catheter Ablation System In The Treatment Of Atrial Fibrillation (Af) In Turkey

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Tiotropium In The Treatment Of Patients With Asthma

    Nov 1, 2015, 00:00

  • Patient-Reported Frequency and Burden of Hypoglycaemia for Insulin-Treated Diabetes Patients In 5 Cities of China- A Cross-Section Study

    Nov 1, 2015, 00:00

  • Costo - efectividad de la combinacion de glicopirronio/indacaterol vs. Salmeterol/ fluticasona (combinacion de dosis fija – cdf) en el manejo de los pacientes con enfermedad pulmonar obstructiva cronica (epoc) en colombia (sur américa)

    Nov 1, 2015, 00:00

  • Pattern And Factors Associated With Readmission In Patients Hospitalized For Chronic Obstructive Pulmonary Disease In Taiwan

    Nov 1, 2015, 00:00

  • Systematic Literature Review of Health State Utilities for Adults With Type 1 Diabetes

    Nov 1, 2015, 00:00

  • Medication-Taking Behaviour in Women with Postmenopausal Osteoporosis (Op) Treated with Denosumab or Monthly Oral Bisphosphonates (Obps)

    Nov 1, 2015, 00:00

  • High-Dose Inactivated Influenza Vaccine can Reduce Costs and Improve Outcomes Compared to Standard-Dose Inactivated Influenza Vaccine in Canadian Seniors

    Nov 1, 2015, 00:00

  • Patient Reported Outcomes in the Development of new Medications for Type 2 Diabetes- a Review of Recently Approved Products

    Nov 1, 2015, 00:00

  • Adjusting For Treatment Switching in Rcts – Identifying, Analysing and Justifying Appropriate Methods- a Case Study in Metastatic Melanoma

    Nov 1, 2015, 00:00

  • Qualitative Assessment of Societal Preferences for Market Access of Cancer Drugs

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Vemurafenib Vs Ipilimumab Plus Dacarbacine in the Treatment of Non-Resectable Metastasic Melanoma with Braf600e Mutation in Colombia

    Nov 1, 2015, 00:00

  • Development of A Precis-2 Scoring Grid- How Pragmatic are Pragmatic Trials of Surgical and Pharmaceutical Interventions?

    Nov 1, 2015, 00:00

  • G-Ba Does not Adjust Evidence Requirements in Early Benefit Assessment in Cases of Pre-Defined, Efficacy-Based Cross-Over Decisions in Oncology Trials

    Nov 1, 2015, 00:00

  • Burden of Spinal Diseases- Results From Register Study In Sweden

    Nov 1, 2015, 00:00

  • Medical Devices – Brest Forms. Cost And Quantity Characteristics Of Medical Devices In Slovakia 2009 – 2013

    Nov 1, 2015, 00:00

  • Hospital Readmissions and Mortality Patterns in a Cohort with Heart Failure- 1 Year Follow-Up from the Brazilian Public Healthcare System Database

    Nov 1, 2015, 00:00

  • Basic Attitude Of Japanese Physicians Towards Healthcare Resource Allocation In A Setting Of Budget Constraints

    Nov 1, 2015, 00:00

  • Comparative Efficacy Of Treatments For Previously Treated Advanced Or Metastatic Non-Small Cell Lung Cancer (Nsclc)- A Network Meta-Analysis

    Nov 1, 2015, 00:00

  • Aligning Patient Centred Evidence Generation Across the Drug Development Lifecycle

    Nov 1, 2015, 00:00

  • Characteristics and Healthcare Resource use of Patients with Major Depressive Disorder Initiated on Snri Compared to Ssri In Beijing China

    Nov 1, 2015, 00:00

  • Eroltinib Plus Gemcitabine Compared With Gemcitabine Monotherapy In Patients With Pancreatic Cancer- A Real-World Analysis Of Korean Nationa-Wide Database

    Nov 1, 2015, 00:00

  • Cost of Type 2 Diabetes According to Glucose-Lowering Medications in France

    Nov 1, 2015, 00:00

  • Does One Size Fit All? - Challenges Faced when Adapting Translations for an Electronic Platform

    Nov 1, 2015, 00:00

  • Estimating Lifetime Medical Costs From Censored Claims Data

    Nov 1, 2015, 00:00

  • Full Economic Assessment of Rotavirus Vaccination Using the Health Economic Cauliflower Toolbox

    Nov 1, 2015, 00:00

  • Quality of Life Among Hiv Patients- Results from the Ianua Clinical Trial

    Nov 1, 2015, 00:00

  • Data Mining Based On Real World Data In Chronic Kidney Disease Patients Not On Dialysis- The Key Role Of Early Hemoglobin Levels Control

    Nov 1, 2015, 00:00

  • Examination of Water Consumption- Knowledge About Water Consumption In Population of Bátya And Pécs

    Nov 1, 2015, 00:00

  • Bayesian Network Meta-Analysis To Assess Relative Efficacy Of Ibrutinib Versus Idelalisib+Ofatumumab And Physician’s Choice In Relapsed/Refractory Cll Patients

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Delayed-Release Dimethyl Fumerate For The Treatment of Relapsing-Remitting Multiple Sclerosis In Portugal

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Obinutuzumab/Chlorambucil Vs Rituximab/Chlorambucil In Treatment Of Chronic Lymphocytic Leukemia

    Nov 1, 2015, 00:00

  • Uptake Of Filgrastim ‘Biosimilars’ In The United States- Analysis Of A Medical Transcription Database Of Patient Office Visits

    Nov 1, 2015, 00:00

  • Regional Versus Centralized Hta- Implications for the Assessment of Cancer Drugs

    Nov 1, 2015, 00:00

  • Descriptive Evalaution of Characteristics of Patients Diagnosed with Relapsing Remitting Multiple Sclerosis and Taking Disease Modifying Agents

    Nov 1, 2015, 00:00

  • Qualitative Equivalence Between Paper and Ediary Versions and Usability of 6 Pro Questionnaires for Endometriosis

    Nov 1, 2015, 00:00

  • The Economic Burden of Brain Disorders In Korea

    Nov 1, 2015, 00:00

  • La Hipoglucemia Incrementa El Gasto En Salud Y Deteriora La Productividad De Pacientes Con Diabetes Tipo 1 Y Tipo 2

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Directly Mailed Fobt Kits To Previous Responders Being Recalled For Screening

    Nov 1, 2015, 00:00

  • Children’s Medication In The Nordic Countries – Survey on National Administrative Register Data

    Nov 1, 2015, 00:00

  • A Cost Effectiveness Analysis of Nivolumab Compared to Ipilimumab for the Treatment of Braf Wild-Type Advanced Melanoma in Australia

    Nov 1, 2015, 00:00

  • Budget Impact Model for Cervical Cancer Screening Using Hpv Tests In Chile

    Nov 1, 2015, 00:00

  • Treatment Patterns Among Front-Line Glioblastoma Patients In Five European Countries

    Nov 1, 2015, 00:00

  • Survey on Romanian Hospitals Financing Reveals Major Dysfunctions In Covering Drug Treatment During Hospitalization

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Exenatide Once-Weekly Versus Dulaglutide, Liraglutide and Lixisenatide for the Treatment of Type 2 Diabetes Mellitus- An Analysis from the UK NHS Perspective

    Nov 1, 2015, 00:00

  • Assessing The Esmo Magnitude of Clinical Benefit Scale From A Health Economics Perspective

    Nov 1, 2015, 00:00

  • Nub Status – An Analysis Comparing Results of 2015 Vs. 2014 - Leading Therapeutic Areas Confirmed

    Nov 1, 2015, 00:00

  • Economic Burden of Type 2 Diabetes Mellitus For Mexico

    Nov 1, 2015, 00:00

  • Influence of Some Factors on The Morphological Structure of Spermatozoa In Straight Intestine During Forensic - Medical Examination of Sodomy

    Nov 1, 2015, 00:00

  • The Medical Technologies Evaluation Programme (Mtep)- An Analysis Of Notifications, Decision-Making And The Interpretation Of Claimed Healthcare System Benefits

    Nov 1, 2015, 00:00

  • Network Meta-Analysis Of Multiple Outcomes Incorporating Dose-Related Constraints- Application To Overactive Bladder Syndrome

    Nov 1, 2015, 00:00

  • Comparison of Direct Hospitalization Costs and Length of Stay In Carbapenem Resistant Versus Carbapenem Sensitive Klebsiella Pneumoniae Infections In A Tertiary Care Hospital

    Nov 1, 2015, 00:00

  • Resource Use And Direct Costs For Managing Hcv Genotype 1 Patients In Colombia

    Nov 1, 2015, 00:00

  • The Cost of Rehumatoid Diseases In Italy- Analysis From An Italian Administrative Database

    Nov 1, 2015, 00:00

  • Medical Costs And Resources Consumption In Patients With Atrial Fibrillation- An Italian Observational Study

    Nov 1, 2015, 00:00

  • Costs Analysis Of Pcr Unyverotm I60-Iti Technique For Detecting Microorganisms In Patients With Suspected Chronic Infection At Musculoskeletal Implants

    Nov 1, 2015, 00:00

  • Effect of Patient-Education on Health-Related Quality of Life of Diabetic Foot Ulcer Patients In A Tertiarycare Hospital

    Nov 1, 2015, 00:00

  • A Simulation Analysis Using The Orange Price Reference Tool

    Nov 1, 2015, 00:00

  • Assessing the Translatability of the Term “Distressed”

    Nov 1, 2015, 00:00

  • Variation In State-Level Vs. National Incidence In Rare Genetic Disease- A Monte Carlo Simulation to Examine Sampling Variation As A Primary Explanation In Congenital Adrenal Hyperplasia

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Romiplostim for The Treatment of Adult Chronic Immune Thrombocytopenic Purpura (Itp) In Brazil

    Nov 1, 2015, 00:00

  • An Assessment of Annual Costs of Patients Hospitalized for Spinal Tumors in Fran Analysis Using the Pmsi Database

    Nov 1, 2015, 00:00

  • A Systematic Literature Review On The Impact Of Therapeutic Interventions On Quality Of Life In Systolic Hf Randomized Clinical Trials

    Nov 1, 2015, 00:00

  • Achievement of Glycaemic Targets with Canagliflozin in Triple Therapy in Patients with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2015, 00:00

  • Medical Devices- Innovative Models To Access The Market Leveraging On Shared Infrastructure Among Payers And Pharmaceutical Companies

    Nov 1, 2015, 00:00

  • Iron Deficiency In Patients With Chronic Heart Failure- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Cognitive Symptoms In Major Depressive Disorder And Their Italian Psychiatrists’ Perception

    Nov 1, 2015, 00:00

  • Economic Evaluation of Voriconazole in the Treatment of Invasive Aspergillosis

    Nov 1, 2015, 00:00

  • Study Of Acute Lower Respiratory Tract Infections In Children Of Age Group 1 Month To 5 Years

    Nov 1, 2015, 00:00

  • 5th LAC Abstracts FDS and 18th Euro Abstracts FDS - Financial Disclosure

    Nov 1, 2015, 00:00

  • Using Decision Making Clinical Scenarios to Appraise Preferences and Value Judgments in Health Technology Assessment (Hta)

    Nov 1, 2015, 00:00

  • Relationship Between The Prevalence Of Cancers In England And Wales And The Performance Of Technology Appraisals

    Nov 1, 2015, 00:00

  • High-Cost Oncologic Medication Access- Why Is Latin America Falling Behind? Case Study In Non-Small Cell Lung Cancer (NSCLC)

    Nov 1, 2015, 00:00

  • Convergent Validity of New Disease Assessment Instruments (Dai) In Systemic Lupus Erythematosus (Sle) In Relation to Sledai-2k

    Nov 1, 2015, 00:00

  • Increase Arv Access for Plwha In Dominican Republic Through The Transition From Vertical Supply System to An Integrated National Pharmaceutical System

    Nov 1, 2015, 00:00

  • Assessment of Burden and Economic Impact of the Vandetanib Restricted Distribution Program in Canada

    Nov 1, 2015, 00:00

  • Resistência Antimicrobiana- Identificação Das Pesquisas Brasileiras Fomentadas Para Suporte À Gestão No País

    Nov 1, 2015, 00:00

  • An Assessment of The Hospitalization Costs of Melanoma in France in the Advanced/Metastatic Setting- the Melissa Study (Melanoma in Hospital Costs Assessment)

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Continuous Remote Monitoring Of Heart Failure Patients With Cardiac Electronic Implantable Device

    Nov 1, 2015, 00:00

  • Relationship Between Adherence To Post Percutaneous Coronary Intervention (Pci) Guidelines And Clinical Outcomes Of Post-Pci Patients In Hong Kong - A 5-Year Retrospective Cohort Study

    Nov 1, 2015, 00:00

  • Assessing The Potential for Tiered Pricing of High Priced Therapies Within Argentina, Columbia, Mexico, Indonesia, and Thailand

    Nov 1, 2015, 00:00

  • Relationship of Time in Therapeutic Range (Ttr) with Bleeding and Stroke Incidences of Warfarinised Patients with Pulmonary Embolism in a Tertiary Hospital in Malaysia

    Nov 1, 2015, 00:00

  • Progressive Disease Does Not Impact Hrqol In Patients Receiving Nivolumab For The Treatment Of Unresectable Or Metastatic Melanoma

    Nov 1, 2015, 00:00

  • Quality of Life in Patients After Total Hip Replacement

    Nov 1, 2015, 00:00

  • Comparative Effectiveness of Triple Antihypertensive Combination Therapy for Patients with Resistant Hypertension In Taiwan

    Nov 1, 2015, 00:00

  • Health-Economic Evaluation of Clostridium Difficile Infection (Cdi) And Epidemiology In England And Merseyside

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Intravitreal Aflibercept In Diabetic Macular Oedema In Sweden

    Nov 1, 2015, 00:00

  • A Systematic Review of Model-Based Economic Evaluations of Drug Substitution Therapies in Maintenance Treatment of Non-Prescription Opioid Dependence

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Transcatheter Aortic Valve Replacement- Current Decision-Analytic Models and Future Opportunities

    Nov 1, 2015, 00:00

  • Patient Perspective on Convenience and Intensification of Insulin Treatment In Type 2 Diabetes In Italy

    Nov 1, 2015, 00:00

  • Descriptive Epidemiology And Treatment Strategies Used In Multiply Myeloma In The Slovak Republic. Results From The Cross-Sectional Survey In The Haematology-Oncological Centers

    Nov 1, 2015, 00:00

  • Using Tangent Line Segments to Determine Statistical Differences between Survival Curves at a Single Point in Time

    Nov 1, 2015, 00:00

  • Study On Cost-Effectiveness Analysis For Multiple Myeloma Treatment- A Systematic Review Of Literature From 2004-2014

    Nov 1, 2015, 00:00

  • Improved Survival In Patients With Advanced Melanoma In Real-World Clinical Practi First Results Of The Dutch Melanoma Treatment Registry

    Nov 1, 2015, 00:00

  • Modelling The Likely Impact of The Obesity Epidemic on Mortality And Cause of Death In Older Adults

    Nov 1, 2015, 00:00

  • Assessment of Who/Inrud Core Drug Use Indicators in two Tertiary Care Hospitals of Bahawalpur, Punjab, Pakistan

    Nov 1, 2015, 00:00

  • Do Socioeconomic Inequalities Impact The Social Cost Of Chronic Kidney Disease In Italy?

    Nov 1, 2015, 00:00

  • Analysis Of Stroke Statistics In Turkey

    Nov 1, 2015, 00:00

  • La Canasta Basica de Medicamentos Como Estrategia Para Mejorar el Acceso y Costo de Los Medicamentos en Panama

    Nov 1, 2015, 00:00

  • Physicians’ Prescribing Pattern For Tuberculosis- Evidences From Community Pharmacies In Punjab, Pakistan

    Nov 1, 2015, 00:00

  • Adherence With Therapeutic Guidelines In The Treatment Of Venous Thromboembolism And Pulmonary Embolism In Clinical Practice. Findings From The Victor Study

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Oral Anticoagulation Therapies (Oat) In China

    Nov 1, 2015, 00:00

  • Current Challenges and Opportunities to Market Access in Brazil, Argentina, Mexico and Colombia

    Nov 1, 2015, 00:00

  • Health Care Coverage Through Private Health Insurance

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Introducing Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the United States

    Nov 1, 2015, 00:00

  • State and Prospects of Pharmacoeconomics Training in Ukraine

    Nov 1, 2015, 00:00

  • Patterns of Utilization and Cost of Prostacylins for Pulmonary Arterial Hypertension

    Nov 1, 2015, 00:00

  • A Microcosting Study Of Radiation Therapy In Localized Prostate Cancer Patients In A Hungarian Tertiary Oncology Center

    Nov 1, 2015, 00:00

  • Economic Analysis Of Evarrest® Sealant Matrix Compared With Standard Of Care In Severe Soft Tissue Surgical Bleeding- An Italian Hospital Perspective

    Nov 1, 2015, 00:00

  • The Power of the Patient Voi Formalising Qualitative Data in the Drug Approval Process

    Nov 1, 2015, 00:00

  • The Indirect Costs of Types 1 Diabetes Mellitus Associated with Absenteeism in Poland in 2013

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Treatments for Wet Age-Related Macular Degeneration (Wamd) In The Netherlands, The Case of Intravitreal Aflibercept (Ivt-Afl) and Ranibizumab

    Nov 1, 2015, 00:00

  • Health-Economic Comparison of a Gnrh-Antagonist (Degarelix) Vs. Gnrh-Agonists Considering the Number-Needed-to-Treat to Avoid Cardiovascular Events

    Nov 1, 2015, 00:00

  • Biopharma Intervention Valuation- An Evidence-Based Appraisal Framework for Oncology Drugs

    Nov 1, 2015, 00:00

  • Which Risk Share Agreements are Available and are Those Applied In Global Reimbursement Decisions?

    Nov 1, 2015, 00:00

  • Fluticasone Propionate Versus Budesonide or Beclomethasone As Monotherapy Treatment for Asthma Patients - A Systematic Review

    Nov 1, 2015, 00:00

  • Impact Of A Novel Ibs Diagnostic Blood Panel For Mexico- Cost Implications To The Mexican Private Practice For Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D)

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Ledipasvir/Sofosbuvir for the Treatment of Genotype 1 Or 4 Chronic Hepatitis C in England and Wales

    Nov 1, 2015, 00:00

  • Network Meta-Analysis for Health Technology Submissions Worldwide- A Report Checklist for Network Meta Analysis Best Practices Globally

    Nov 1, 2015, 00:00

  • A Review of Guidelines And Approaches to Performance-Based Risk-Sharing Agreements Across The Uk, Italy And The Netherlands

    Nov 1, 2015, 00:00

  • Geographical Disparities in Colon Cancer Care in Europe- Implications for Access to Innovative Medicines Via the UK Cancer Drugs Fund

    Nov 1, 2015, 00:00

  • Effectiveness Of Supporting Informal Caregivers Of People With Dementia- A Systematic Review

    Nov 1, 2015, 00:00

  • Network Meta-Analysis On Prevention Of Stroke For Patent Foramen Ovale Closure

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Apremilast for The Treatment of Moderate to Severe Psoriasis In Spain

    Nov 1, 2015, 00:00

  • The Burden of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Fran A Comparison With The European Results From The Ibis-C Observational Study

    Nov 1, 2015, 00:00

  • Humanistic Burden of Chronic Spontaneous Urticaria in Comparison to Psoriasis- European Perspective

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Insulin Analogues Compared with Multiple Daily Injections of Human Insulin for the Treatment of 15 Years Old or Older Patients with Type 1 Diabetes Mellitus in Colombia

    Nov 1, 2015, 00:00

  • Análisis de Costo Efectividad y Costo Utilidad de Rituximab Como Tratamiento en Pacientes Con Artritis Reumatoide, Ante el Fallo o Intolerancia en Primera Línea de un Anti-Tnf, en el Contexto Venezolano

    Nov 1, 2015, 00:00

  • Generalized Implementation of Em Algorithm for Estimation of Transition Probability Matrix

    Nov 1, 2015, 00:00

  • Inadequate Treatment of Post-Surgical Pain May Result in Extended Hospitalization Period

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of Ferric Carboxymaltose in Patients with Colon Cancer and Anemia

    Nov 1, 2015, 00:00

  • How to Calculate Value of Information in Seconds Using ‘Savi’, the Sheffield Accelerated Value of Information Web App

    Nov 1, 2015, 00:00

  • Contrasting Predictions of Cardiovascular Incidence Derived From Alternative Risk Prediction Models In Type 1 Diabetes

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis Of Apixaban In The Acute Treatment And Prevention Of Venous Thromboembolism In France

    Nov 1, 2015, 00:00

  • Evaluation of Inpatients’satisfaction in Pafos General Hospital, Cyprus

    Nov 1, 2015, 00:00

  • Hurdles That Impede Economic Evaluations of Health Care Interventions Tested By General Practitioners In Flanders- A Qualitative Study

    Nov 1, 2015, 00:00

  • Simulating Individual Patient Level Data Using An Illness-Death Modelling Framework In Order to Adjust for Treatment Switching When Only Summary Data Are Available

    Nov 1, 2015, 00:00

  • Inclusion Of A Novel Ibs Blood Panel For Diagnosing Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D)- A Uk Perspective

    Nov 1, 2015, 00:00

  • How Pricing And Reimbursement Policies Affect The Budget Impact of The Treatment of Systemic Juvenile Idiopathic Arthritis In Turkey

    Nov 1, 2015, 00:00

  • Scoping Review of Publicly Available Performance Information in Argentina, Chile and Colombia

    Nov 1, 2015, 00:00

  • Impact Of Her2 Testing Quality Improvement From A Health Economic Perspective

    Nov 1, 2015, 00:00

  • Budget Impact Analysis In The Uk Setting – Know Your Audience

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Blood Clotting Factor Concentrates In The Treatment of Von Willebrand Disease

    Nov 1, 2015, 00:00

  • Benchmarking Health Technology Assessment (Hta) Agencies for Setting Standards on Pharmacoeconomic, Pricing, Evidence, and General Submission Requirements- development of a Multidimensional Rating Scale

    Nov 1, 2015, 00:00

  • Prescription Pattern of Outpatient Department of A Teaching Hospital Quetta, Pakistan

    Nov 1, 2015, 00:00

  • The Economic Consequences of the use of Antidepressants in Belgium- Prescribing Behavior and Misuse of Antidepressants

    Nov 1, 2015, 00:00

  • How to Determine The Target Population In Early Benefit Assessments In Germany? The Case of Diabetes Mellitus Type 2

    Nov 1, 2015, 00:00

  • The Association of Waist Circumference with Glycaemic Control in Diabetic Patients in an Asian Population

    Nov 1, 2015, 00:00

  • A One-Year Follow-Up of Individuals with Diabetes at Very High Cv Risk Treated With Statins- Outcomes and Health Care Costs

    Nov 1, 2015, 00:00

  • An Analysis of German G-BA Added Benefit Assessment Decisions Using the World Health Organization Daly Framework

    Nov 1, 2015, 00:00

  • The Trends In Orphan Drug Authorisation and Approval In Europe And In The United States - A Retrospective Study (2005-2014)

    Nov 1, 2015, 00:00

  • Social Utility Values for Pemphigus Vulgaris and Foliaceus- A Composite Time Trade-Off Study

    Nov 1, 2015, 00:00

  • General Assessment Of Unlicensed Medicine Usage In Turkey

    Nov 1, 2015, 00:00

  • Selective Retina Therapy

    Nov 1, 2015, 00:00

  • Recent Update to Russia’s Essential Drugs List and Seven Nosologies- Clinical Differentiation And Local Manufacturing Implications for New Drug Inclusion

    Nov 1, 2015, 00:00

  • Eficacia Y Seguridad Del Uso Del Cetuximab En Pacientes Con Cancer Colorrectal Metastásico

    Nov 1, 2015, 00:00

  • Screening Guidelines And Cancer Stage- Early Findings From Medicare

    Nov 1, 2015, 00:00

  • Economic Evaluation of Fecal Microbiota Transplantation for The Treatment of Recurrent Clostridium Difficile Infection In Australia

    Nov 1, 2015, 00:00

  • Estimating The Economic Consequences Of An Increased Medication Compliance Due To A Potential Improvement Of The Inhaler Technique With Spiromax® Compared With Turbuhaler® In Moderate To Severe Patients With Copd In Spain

    Nov 1, 2015, 00:00

  • The Survey of Physicians’ Satisfaction of Implementing Interventions for Changing Prescribing Behavior Toward Rational Medicine Use-2014

    Nov 1, 2015, 00:00

  • Quality Of Life In Women Patients With Urinary Incontinence In Slovakia

    Nov 1, 2015, 00:00

  • Are Spanish Regions Implementing The National Therapeutic Positioning Report (Tpr) Regarding New Oral Anticoagulants (Noac) In The Same Way? A Case Of Regional Variability In Drug Access

    Nov 1, 2015, 00:00

  • Promis® Physical Function Multilingual Translations- Progress And Outlook

    Nov 1, 2015, 00:00

  • Cost-Savings And Cost-Utility Of An Ehr System Smartphone App In A Trauma Intensive Care Unit

    Nov 1, 2015, 00:00

  • The Value of Achieving Complete or Near Complete Resolution of Psoriasis

    Nov 1, 2015, 00:00

  • The Comparative Pharmacoeconomic Analysis Of Using Plerixafor For Stem Cell Mobilization For Autologous Peripheral Stem Cell Transplantation For Non-Hodgkin’s Lymphoma Patients

    Nov 1, 2015, 00:00

  • Biologics In Ulcerative Colitis (Uc)- Treatment Guidelines and Health Technology Assessments (Hta)

    Nov 1, 2015, 00:00

  • Performance of Drg-Based Reimbursement Policy In National Health Insurance - Eight Years’ Experiences

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis Of The Combined Homocysteine-Lowering And Standard Therapy Versus Standard Therapy Of Patients With Chd, Postpercutaneous Coronary Intervention (Pci) And B12 Deficiency

    Nov 1, 2015, 00:00

  • Anemia Treatment Cost in Patients with Chronic Kidney Disease (A-Ckd) In The Mexican Social Security Institute (Imss)

    Nov 1, 2015, 00:00

  • Students’ Knowledge and Perceptions Towards Quality Use of Medicines- A Descriptive Analysis From Universiti Sains Malaysia

    Nov 1, 2015, 00:00

  • Cost Effectiveness of Triple Therapy for Adults Patients with Genotype 1 Chronic Hepatitis C

    Nov 1, 2015, 00:00

  • Real-World Hepatitis C Treatment Strategies in Denmark

    Nov 1, 2015, 00:00

  • Potential Long-Term Cost Savings In Treatment of Naïve Hiv-Infected Patients With Rilpivirine/ Tenofovir/ Emtricitabine (Single Tablet Regimen) In The Russian Federation

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Ceritinib Versus Current Therapies for Chemotherapy-Experienced Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients in Mexico

    Nov 1, 2015, 00:00

  • When “Alive After 5 Years” Does Not Mean “Cured”- International Patterns In Cancer 10- To 20- Year Relative Survival Rates

    Nov 1, 2015, 00:00

  • Pilot Assessment Of Pharmaceuticals Based On The Eunethta Core Model For Rapid Relative Effectiveness Assessment

    Nov 1, 2015, 00:00

  • Economic Evaluation Of The Rotavirus Vaccination Among Children Under 5 Years Of Age In Switzerland

    Nov 1, 2015, 00:00

  • Costs Of Compression Therapy In Venous Leg Ulcers In Germany And Modelling Of The Economic Effects Of Regional Disparities In Health Care

    Nov 1, 2015, 00:00

  • Value Assessment and Pricing Frameworks for Rare Disease Treatments- New Approaches From The Literature

    Nov 1, 2015, 00:00

  • Development of an Eq-5d Respiratory Bolt-on

    Nov 1, 2015, 00:00

  • Hospitalization Costs of Type 2 Diabetes Mellitus (T2dm) Patients In A Public Hospital In Brazil

    Nov 1, 2015, 00:00

  • Impact of Indiscriminate Use of Pump Infusion Set (Pis) on the Cost of Chemotherapy Treatments- A Cost Minimization Study

    Nov 1, 2015, 00:00

  • Cost-effectiveness of Ranibizumab Vs. Dexamethasone Implant In Diabetic Macular Edema

    Nov 1, 2015, 00:00

  • Monitored Cognitive Debriefing Interviews- a Case Study

    Nov 1, 2015, 00:00

  • Therapeutic and Economic Value of Everolimus Plus Exemestane for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, Her2/Neu Negative Advanced Breast Cancer

    Nov 1, 2015, 00:00

  • Clinical Characteristics and Patterns of Care Among Patients With Genotype 1 (G1) Hepatitis C Virus In Europe (Eu)

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Ponatinib In The Treatment of Chronic-Phase Chronic Myeloid Leukemia (Cp-Cml) In Sweden

    Nov 1, 2015, 00:00

  • The Budget Impact Analysis of Adjunctive Therapy for Patients With Partial Epilepsy

    Nov 1, 2015, 00:00

  • Defibrotide in Veno-Occlusive Disease in Public Hospitals of Paris- Funding Issues and Perspectives

    Nov 1, 2015, 00:00

  • The Economic Value Proposition of Hand-Sewn Suture Versus Stapled Anastomoses During Right Colon Surgery

    Nov 1, 2015, 00:00

  • Health Care Costs Associated With Geriatric Patients Diagnosed With Multiple Sclerosis Taking Disease Modifying Agents In The United States

    Nov 1, 2015, 00:00

  • Clinical Responses and Improvements in Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Axial Spondyloarthritis Patients Treated with Certolizumab Pegol

    Nov 1, 2015, 00:00

  • Valuation of Eq-5d Health States by Pharmacy Students in Poland (Comparison of Different Methods and with General Population)

    Nov 1, 2015, 00:00

  • Costo Efectividad De La Hemodiálisis En Los Prestadores De Servicios De Dos Aseguradoras A Través De La Evaluación De Indicadores Mínimos Para El Análisis De Resultados Clínicos De La Terapia Dialítica En Colombia

    Nov 1, 2015, 00:00

  • Stimulant Use and Cardiovascular Risk Among Children And Adolescents With Adhd- What Product Labeling Does, or Does Not, Tell Us

    Nov 1, 2015, 00:00

  • Meta-Analysis of Mortality In Adults, Newborns and Older Children With Bacterial Infections And Sepsis When Treated By Igm-Enriched Intravenous Immunoglobulins And Standard Schemes

    Nov 1, 2015, 00:00

  • Effects Of Adverse Events On Quality Of Life Scores In A Randomized Clinical Trial Of Adjuvant Chemotherapy For Breast Cancer- N-Sas Bc 02

    Nov 1, 2015, 00:00

  • Patient Heterogeneity In Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (Copd)- are Current Models Suitable to Evaluate Personalized Medicine

    Nov 1, 2015, 00:00

  • Equity in Access to High Cost Drugs in Uruguay

    Nov 1, 2015, 00:00

  • Identifying The Optimal Use Of Ctcs In The Early Staging Phase Of Breast Cancer

    Nov 1, 2015, 00:00

  • Comparison Between The Interim Eq-5d-5l Score And The New Japanese Scoring In Stroke Patients

    Nov 1, 2015, 00:00

  • Current Perception of Upcoming Cost-Effectiveness Requirements in Japan- a Survey on the Perspective of Pharmaceutical Industry

    Nov 1, 2015, 00:00

  • Hematological Toxicities Associated with Pazopanib use in Cancer Patients- A Meta-Analysis

    Nov 1, 2015, 00:00

  • Gender Differences in Medication Taking Behaviour- A Case of Osteoporosis

    Nov 1, 2015, 00:00

  • Sipuleucel-T (Provenge®)- Autopsy of an Innovative Change of Paradigm in Cancer Treatment

    Nov 1, 2015, 00:00

  • Son útiles los enfoques de separación de funciones y cadena de valor para mejorar la organización, regulación y acceso a medicamentos?

    Nov 1, 2015, 00:00

  • Re-Use Of Insulin Syringe Needles And Its Extra Disease Burden For Diabetic Patients In Beijing

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Apremilast In Patients With Psoriatic Arthritis In Spain

    Nov 1, 2015, 00:00

  • Estimation of The Progression of Colon Cancer By Japanese Large-Scale Insurance Benefits Data Analysis

    Nov 1, 2015, 00:00

  • The Quality Of Life In Patients 12 Months After An Acute Coronary Syndrom- Results From The Pgrx-3 Real World Dataset

    Nov 1, 2015, 00:00

  • Acromegaly Patients with Inadequate Response to Maximum Dose Octreotide-Lar Who Progress to Treatment with Pegvisomant- Economic Evaluation and Incremental Budget Impact Analysis from the Public Perspective to São Paulo State

    Nov 1, 2015, 00:00

  • Shaping European Early Dialogues- The Seed Project

    Nov 1, 2015, 00:00

  • Efficiency Analysis of Surgical Staplers Compared to Manual Suture for Open And Laparoscopic Surgery

    Nov 1, 2015, 00:00

  • Access to Healthcare Among International Immigrants in Chile- Repeated Cross-Sectional Analysis of Casen Survey 2006-2009-2011

    Nov 1, 2015, 00:00

  • A Scotland Based Cost-Effectiveness Analysis Of Idelalisib (Zydelig®) In Combination With Rituximab For The Treatment Of Adults With Chronic Lymphocytic Leukaemia Cll)

    Nov 1, 2015, 00:00

  • Development of a Prediction Model of Disease Activity in Support of Clinical Practice – the Acrodat Experience

    Nov 1, 2015, 00:00

  • Association of Medication Persistency with Route of Administration and Patient Cost-Sharing- Analysis of Commonly Used Biologics

    Nov 1, 2015, 00:00

  • Economic Burden of Type 2 Diabetes Mellitus Treatment Strategies- A Cost Consequence Analysis of Sitagliptin vs Sulfonylureas in Lombardy Region

    Nov 1, 2015, 00:00

  • UNDERSTANDING THE RELATIONSHIP BETWEEN HEALTH ASSESSMENT QUESTIONNAIRE-DISABILITY INDEX (HAQ-DI), PSORIASIS AREA SEVERITY INDEX (PASI), AND QUALITY OF LIFE (QOL) AND ITS INFLUENCE ON COST-EFFECTIVENESS IN PSORIATIC ARTHRITIS (PSA)

    Nov 1, 2015, 00:00

  • Heart Failure Management- A Nationwide Population-Based Cohort Study Using The French Egb Database

    Nov 1, 2015, 00:00

  • Basal Insulin Regimens- Systematic Review, Network Meta-Analysis, and Cost - Utility Analysis for the National Institute For Health and Care Excellence (Nice) Clinical Guideline on Type 1 Diabetes Mellitus in Adults

    Nov 1, 2015, 00:00

  • Reimbursement of Orphan and Expensive Drugs In The Netherlands- Exploration of Essential Criteria In The Decision Making Process

    Nov 1, 2015, 00:00

  • Adverse Drug Reactions, Medication Adherence and Physicians’ Prescribing Behavior- Which Relationship? a Database Analysis on Statin use

    Nov 1, 2015, 00:00

  • Mammography For Breast Cancer Screening In India – A Health Technology Assessment

    Nov 1, 2015, 00:00

  • Economic Evaluation of Children Vaccination from 2 To 18 Years of age with the Live attenuated Influenza Vaccine ComparED with the Existing Vaccines in the Portuguese Setting

    Nov 1, 2015, 00:00

  • Using Incentives to Improve Health-Related Behaviours- A Review of Incentive-Based Trials

    Nov 1, 2015, 00:00

  • Atc1 Group Discount Distribution Analysis of Original Medicines Which Has No Generics In Turkey

    Nov 1, 2015, 00:00

  • Using The Transtheoretical Model to Enhance Self-Management Activities In Type 2 Diabetic Patients- A Systematic Review

    Nov 1, 2015, 00:00

  • A Mixed Treatment Comparison (Mtc) to Compare the Efficacy of Anti-Thrombotic Agents in the Acute Treatment of Venous Thromboembolism (Vte) in Patients with Active Cancer

    Nov 1, 2015, 00:00

  • Predictors of 10-Year Mortality After Primary Femoral Neck Fracture In Elderly Patients

    Nov 1, 2015, 00:00

  • Device Inhalators In Asthma and Their Impact on Treatment Adherence

    Nov 1, 2015, 00:00

  • Clinical Pathway And Health Care Resources Utilization Of A Patients Cohort At High Risk Of Cardiovascular Disease Of Local Healthcare Unit (Asln°1) Of Milan- A Results Of Intervention On Secondary Prevention

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Active Surveillance Of Carbapenem-Resistant Enterobacteriaceae In Intensive Care Units In Hong Kong

    Nov 1, 2015, 00:00

  • Irrational Drug Use Pattern In Hospitals. A Warning for Health Care System

    Nov 1, 2015, 00:00

  • Prediction Model for Functional Status at Discharge Following Rhabilitation After Intracerebral Hemorrhage

    Nov 1, 2015, 00:00

  • Costo-Efectividad De La Cuantificaci”N De La Actividad Enzimática En Leucocitos En Comparaci”N A Su No Realizaci”N Para La Confirmaci”N Diagn”Stica De La Mucopolisacaridosis Tipo Iva En Colombia

    Nov 1, 2015, 00:00

  • Impact Of Staging And Hormone Sensitivity On Quality Of Life In Us Prostate Cancer Patients

    Nov 1, 2015, 00:00

  • Clinical and Economic Impact of Chronic Heart Failure in General Practi Analysis of 13.633 Patients

    Nov 1, 2015, 00:00

  • Italian Healthcare Expenditure Trends From 2002 To 2013

    Nov 1, 2015, 00:00

  • Effectiveness of A Referral Program for Early Arthritis Diagnosis At Primary Care Centers in Portugal - Preliminary Results from the Siara Study

    Nov 1, 2015, 00:00

  • Avoiding Anything ‘Abnormal’ in the Translation of ‘Usually’

    Nov 1, 2015, 00:00

  • Efficiency Assessments of Pharmaceuticals and Medical Devices In Fran A 2 Years Update

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Tobacco Dependence Treatment In The Czech Republic

    Nov 1, 2015, 00:00

  • Benefícios Materiais Como Incentivo Para Redução de Abandono de Tratamento de Tuberculose em Pessoas Vivendo em Situação de Rua- Revisão de Análises Econômicas

    Nov 1, 2015, 00:00

  • Life Quality of Young Adult Patients With Inflammable Bowel Disease

    Nov 1, 2015, 00:00

  • Do Patient Reported Outcomes (Pro) In Oncology Matter In Health Technology Assessments (Hta)?

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness Analysis of Philips Motiva Telehealth System- A Comparison Between Home Telemonitoring, Nurse Telephone Support And Usual Care In Chronic Heart Failure

    Nov 1, 2015, 00:00

  • Effectiveness and Side Effects of Oseltamivir for Influenza Treatment- A Meta-Analysis of Meta-Analysis

    Nov 1, 2015, 00:00

  • Evaluation of the Burden of Opioid Abuse Among us Veteran Patients

    Nov 1, 2015, 00:00

  • When is it Evening, When is it Night? why it is Challenging to Translate Times of the Day in Clinical Translations

    Nov 1, 2015, 00:00

  • Role Of Pharmacoeconomic Analysis In Pricing Decision In Japan

    Nov 1, 2015, 00:00

  • Timed Automata Modeling of The Personalized Treatment Decisions In Metastatic Castration Resistant Prostate Cancer

    Nov 1, 2015, 00:00

  • Do Access Restrictions Always Imply Cost Reduction? Case of Turkish Dpp4 Market In Treatment of Type Ii Diabetes

    Nov 1, 2015, 00:00

  • Risk of Incident Chronic Kidney Disease and End-Stage Renal Disease in Patients with Psoriasis- a Nationwide Population-Based Cohort Study

    Nov 1, 2015, 00:00

  • Hunting For Randomised Controlled Trials (Rcts)- A Comparison Of Search Filters Designed To Identify Rcts

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness Of Regorafenib In The Treatment Of Metastatic/Inoperable Gastrointestinal Stromal Tumors In Turkey

    Nov 1, 2015, 00:00

  • Characteristics of Pediatric Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents

    Nov 1, 2015, 00:00

  • Cancer And Premature Mortality In Ireland- An Employer’s Perspective Following The Friction Cost Approach

    Nov 1, 2015, 00:00

  • A Method Based on the Remaining Value of Perfect Information for the Sample Size Calculation in Randomized Trial-Based Cost-Effectiveness Analyses

    Nov 1, 2015, 00:00

  • A Next-Generation Framework- Deciding On The Role Of Costs In The Clinical Use Of Targeted Gene Panels, Exome And Genome Sequencing

    Nov 1, 2015, 00:00
  • «
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97 (current)
  • 98
  • 99
  • 100
  • »